A new technique using patients’ own modified cells to treat Crohn’s disease has been proven to be effective in experiments using human cells, with a clinical trial of the treatment expected to start in the next six months.
Researchers at the NIHR Guy’s and St Thomas’ Biomedical Research Centre (BRC) developed the technique by studying white blood cells taken from patients who have Crohn’s disease, and comparing them to cells of healthy people. Their findings allowed cell therapy specialists in the BRC to develop a treatment involving taking patients’ cells, and growing them in a special culture so that they behave more like cells from healthy people.
The research, published in the journal Gastroenterology, shows that this technique is effective in human cells, meaning it is ready for use in a clinical trial. The proposed Tribute Trial will test whether the treatment is safe and effective for treating Crohn’s disease.
Crohn’s disease is a lifelong condition in which parts of the digestive system become severely inflamed, causing a range of symptoms such as diarrhoea, stomach aches, tiredness and weight loss. Its causes are unknown, but the immune system is known to play a part. The often debilitating condition is estimated to affect around 620,000 people in the UK.
Professor Graham Lord, previously Director of our BRC, led the research. He recently took up a role as Vice-President and Dean of the Faculty of Biology, Medicine and Health at the University of Manchester. He said:
“This is the next frontier in cell therapy, as we’re going beyond treating the symptoms of Crohn’s disease, and trying to reset the immune system to address the condition.
“It’s a real home-grown treatment in the sense that we started with observing cells and tissues donated by patients at Guy’s and St Thomas’, have developed a treatment, and are now starting to undertake trials, all at the Trust. It shows how central patients are to research, helping to create a treatment that might help thousands more people.”
Rachel Sawyer, a communications manager who is 50 and lives in Anerley in south east London, was diagnosed with Crohn’s disease in 2000 and treated at Guy’s and St Thomas’. Although her condition is now under control, she supports other people who have Crohn’s and runs the Twitter account @Bottomline_IBD.
She said: “One of the worst things for me was the unpredictability, particularly around needing the toilet in a hurry. Having Crohn’s completely re-routes your daily life and makes it hard to do the normal things most of us take for granted like going out socially or taking public transport. Even now, the fear of it is never really far from my mind.
“Another difficult thing is the stigma associated with bowel disease. It’s difficult to talk and be open about it, even with family and friends. I found life very isolating and challenging at times – and that’s something so many people with Crohn’s experience, regardless of whether they were diagnosed years ago or last month. For people diagnosed young, it can impact on the formative years of their life.
“Anything that could help people with Crohn’s have the confidence to go out and get back to being the people they were destined to be would be a game-changer.”
The researchers found that specialised white blood cells called regulatory T cells from Crohn’s patients produced less of a gut-specific protein called integrin ?4?7 than regulatory T cells from healthy people. Working with the specialists at the NIHR Guy’s and St Thomas’ BRC’s Advanced Therapies Manufacturing Platform, they developed a cell therapy technique based on these findings.
This technique involves developing cells from the Crohn’s disease patients with a molecule called RAR568, which restores healthy levels of integrin ?4?7. The cells are then given back to patients by intravenous infusion.
The Latest on: Crohn’s disease
via Google News
The Latest on: Crohn’s disease
- Takeda and Arrowhead Collaborate to Co-Develop and Co-Commercialize ARO-AAT for Alpha-1 Antitrypsin-Associated Liver Diseaseon October 8, 2020 at 4:31 am
alpha-1 antitrypsin-associated liver disease, Crohn’s disease, and acute pancreatitis, among others. Together with researchers, patient groups and more, we are working to advance scientific research ...
- Doc ‘A Space In Time’, About A Family’s Battle With A Rare Childhood Disease, Secures UK Release & International Distributionon October 8, 2020 at 4:29 am
A Space In Time, director Nick Taussig’s documentary response to the diagnosis of his two sons, Theo and Oskar, with Duchenne muscular dystrophy, a fatal muscle wasting disease, will be released in ...
- Crohn’s Disease - Global Drug Forecast and Market Analysis to 2029on October 8, 2020 at 12:40 am
Disclaimer | Commerce Policy | Made In NYC | Stock quotes by finanzen.net New York, Oct. 08, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Crohn’s Disease ...
- Fresenius Medical Care North America Partners with Livongo to Empower People with Chronic Kidney Diseaseon October 7, 2020 at 4:47 pm
Fresenius Medical Care North America (FMCNA), the nation's leading renal care company, today announced an innovative partnership with Livongo Health, Inc., the leading Applied Health Signals company, ...
- Why My Choices Matter in Life With Crohn's Diseaseon October 6, 2020 at 11:55 pm
It helps me get through the rough patches so I’m not constantly focusing on the downside of Crohn’s disease. First, I always make sure my medications and hospitalizations list is always up-to-date, ...
- Researchers Identify Bacteria Responsible for Key Crohn's Complicationon October 6, 2020 at 12:06 pm
Leaking bacteria from the intestine triggers "creeping fat" that often occurs in people with Crohn's disease, according to a new study. Creeping fat is abdominal fat that wraps around the intestines ...
- Sugar Can Make Symptoms of This Disease Worseon October 6, 2020 at 7:12 am
A new study finds that eating too much fructose can increase the symptoms of inflammatory bowel disease, like diarrhea and stomach cramping.
- Disease Risk and Health Test Market 2020 Global Leading Companies Analysis, Revenue, Trends and Forecasts 2026on October 5, 2020 at 11:09 am
New Study Reports “Disease Risk and Health Test Market 2020 Global Market Opportunities, Challenges, Strategies and Forecasts 2026” has been Added on WiseGuyReports. This report provides in depth ...
- Global Crohn's Disease Epidemiology Forecast Report 2019-2029 - ResearchAndMarkets.comon October 5, 2020 at 2:16 am
Epidemiology Forecast to 2029" report has been added to ResearchAndMarkets.com's offering. Crohn's disease (CD) is an inflammatory bowel disease (IBD) characterized by chronic inflammation of the ...
- Crohn's Disease Market Outlook 2020 Pricing Strategy, Industry Latest News, Top Company Analysis, Research Report Analysis & Share By Forecast 2026on September 30, 2020 at 12:38 am
The Global Crohn's Disease Market 2020 Global Industry Size, Share, Forecasts Analysis, Company Profiles, Competitive Landscape and Key Regions 2026 Analysis, Latest Innovations, Impacting Factors, ...
via Bing News